Theratechnologies
Presence
Theratechnologies is one of the...
Theratechnologies is a company listed under the stock ticker TH (CA).
Executives
View the org chart displaying its 16 main executives
Most searched biographies at Theratechnologies
- Paul Lévesque, Director, President and Chief Executive Officer
- Dawn Svoronos, Chairman of the Board
- Gerald Lacoste, Corporate Director
Popular executive movements at Theratechnologies
- Elina Tea has joined the company as Director (posted on April 8 2024).
- Jordan Zwick has joined the company as Director (posted on March 22 2024).
- Alain Trudeau, Director, has left the company (posted on March 1 2024).
Create your alert
to follow the executive moves at Theratechnologies.
Pharmaceuticals
Theratechnologies has 1,867 competitors including Pfizer (United States (USA)), Sanofi (France) and Johnson & Johnson (United States (USA)).
Popular M&A news in Pharmaceuticals
- AstraZeneca has announced the acquisition of Fusion Pharma (posted on March 23 2024).
- AstraZeneca has announced the acquisition of Amolyt Pharma (posted on March 19 2024).
- Frontier Medicines has just announced a $80 Million fundraising (posted on February 27 2024).
Popular contacts in Pharmaceuticals
News
Press releases by Theratechnologies
- Theratechnologies to Present at the Canaccord Genuity 42nd Annual Growth Conference | Theratechnologies Inc.
- Theratechnologies Trogarzo® Data at AIDS 2022 Shows Potential for Improved Treatment Regimens | Theratechnologies Inc.
- Theratechnologies Announces Closing of Funding of $40 Million Under the Terms of its Credit Agreement | Theratechnologies Inc.
- Theratechnologies Provides Update on the Dose Escalation Portion of Fast Track Designated TH1902 First-in-Human Study in Advanced Resistant Malignancies | Theratechnologies Inc.
- Theratechnologies Reports Second Quarter and First Half Fiscal 2022 Financial Results and Provides Business Update | Theratechnologies Inc.
- Theratechnologies Announces Binding Commitment for a Non-Dilutive Term Loan of up to $100 million from Marathon Asset Management | Theratechnologies Inc.
- CQDM, the Quebec Breast Cancer Foundation and Theratechnologies fund close to $2 million for research project to validate the anti-metastatic potential of TH1902 at the Université du Québec à Montréal | Theratechnologies Inc.
- Theratechnologies to Announce Second Quarter 2022 Financial Results and Provide Business Update | Theratechnologies Inc.
- Press Releases | Theratechnologies Inc.
- Theratechnologies Announces New Head of Investor Relations | Theratechnologies Inc.
- View more press releases Close
Social media about Theratechnologies
- Theratechnologies on Wikipedia, Google News & Yahoo Finance
- Theratechnologies on LinkedIn, Twitter & YouTube
Get in Touch
Contact by email its executives including Paul Lévesque 
Call Theratechnologies at +1 514...
